Concepedia
Statistics
Publications
10
Citations
818
H-Index
Active since
1980
Affiliations
Moffitt Cancer Center(Current)
The University of Texas MD Anderson Cancer Center
Dana-Farber Cancer Institute
Cleveland Clinic
Johns Hopkins University
John Puskas is an author at Moffitt Cancer Center specializing in medicine, oncology, and molecular oncology.
Publications per year
1980–2022
Eprenetapopt (APR-246) and Azacitidine in <i>TP53</i>-Mutant Myelodysplastic Syndromes
David A. Sallman, Amy E. DeZern, Guillermo Garcia‐Manero et al. · Journal of Clinical Oncology · 2021 · 460 citations · Full text
Medicine, Oncology, Pharmacology +5
Phase 2 Results of APR-246 and Azacitidine (AZA) in Patients with TP53 mutant Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia (AML)
David A. Sallman, Amy E. DeZern, Guillermo Garcia‐Manero et al. · Blood · 2019 · 73 citations
Medicine, Oncology, Pharmacotherapy +16
Phase 1b/2 Combination Study of APR-246 and Azacitidine (AZA) in Patients with TP53 mutant Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
David A. Sallman, Amy E. DeZern, David P. Steensma et al. · Blood · 2018 · 67 citations
Medicine, Oncology, Pharmacology +17
Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteases
John Puskas, Denise Skrombolas, Abigail L. Sedlacek et al. · Immunology · 2011 · 54 citations · Full text
Life Sciences, Immunology, Oncology +17
Photodynamic therapy mediates the oxygen-independent activation of hypoxia-inducible factor 1α
Soumya Mitra, Scott E. Cassar, David J. Niles et al. · Molecular Cancer Therapeutics · 2006 · 50 citations
Life Sciences, Cell Biology, Molecular Biology +17
1–5 of 10